Molecule Details
InChIKeyOAVGBZOFDPFGPJ-UHFFFAOYSA-N
Compound NameSotrastaurin
Canonical SMILESCN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)42
Pfam Stratification Cross-Family
Avg pChEMBL7.14
SourceChEMBL;BindingDB;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB12369
Drug NameSotrastaurin
CAS Number425637-18-9
Groups investigational
ATC Codes nan
DescriptionSotrastaurin has been used in trials studying the basic science and treatment of Uveal Melanoma, Richter Syndrome, Prolymphocytic Leukemia, Recurrent Mantle Cell Lymphoma, and Recurrent Small Lymphocytic Lymphoma, among others.

Categories: Heterocyclic Compounds, Fused-Ring
Cross-references: BindingDB: 33971 ChEBI: 90531 CHEMBL565612 ChemSpider: 8472351 PDB: LW4 PubChem:10296883 PubChem:347828620 ZINC: ZINC000003973984
Target Activities (42)
Target Gene Organism Category Pfam pChEMBL Type Source
Q04759 PRKCQ Homo sapiens Human PF00130 PF21494 PF00069 PF00433 9.0 IC50 ChEMBL;BindingDB
Q05655 PRKCD Homo sapiens Human PF00130 PF21494 PF00069 PF00433 8.9 IC50 ChEMBL;BindingDB
Q9P1W9 PIM2 Homo sapiens Human PF00069 8.8 Ki ChEMBL
P05771 PRKCB Homo sapiens Human PF00130 PF00168 PF00069 PF00433 8.7 IC50 ChEMBL;BindingDB
O94806 PRKD3 Homo sapiens Human PF00130 PF00169 PF00069 PF25525 8.7 IC50 ChEMBL
P17252 PRKCA Homo sapiens Human PF00130 PF00168 PF00069 PF00433 8.7 IC50 ChEMBL;BindingDB
P18505 GABRB1 Homo sapiens Human PF02931 PF02932 8.7 pIC50 TTD_MultiTarget
P24723 PRKCH Homo sapiens Human PF00130 PF00168 PF00069 PF00433 8.2 IC50 ChEMBL;BindingDB
Q02156 PRKCE Homo sapiens Human PF00130 PF00168 PF00069 PF00433 8.2 IC50 ChEMBL;BindingDB
Q8N4C8 MINK1 Homo sapiens Human PF00780 PF00069 7.7 Kd ChEMBL
P05129 PRKCG Homo sapiens Human PF00130 PF00168 PF00069 PF00433 7.5 IC50 ChEMBL
Q13557 CAMK2D Homo sapiens Human PF08332 PF00069 7.5 Ki ChEMBL
Q9UKE5 TNIK Homo sapiens Human PF00780 PF00069 7.4 Kd ChEMBL
P11309 PIM1 Homo sapiens Human PF00069 7.3 IC50 ChEMBL;BindingDB
P53350 PLK1 Homo sapiens Human PF00069 PF00659 7.2 Ki ChEMBL
Q05513 PRKCZ Homo sapiens Human PF00130 PF00564 PF00069 PF00433 7.2 Ki ChEMBL
Q13555 CAMK2G Homo sapiens Human PF08332 PF00069 7.1 Ki ChEMBL
P49760 CLK2 Homo sapiens Human PF00069 6.9 Kd ChEMBL
P24941 CDK2 Homo sapiens Human PF00069 6.9 Ki ChEMBL
P51812 RPS6KA3 Homo sapiens Human PF00069 PF00433 6.9 Ki ChEMBL
Q13188 STK3 Homo sapiens Human PF11629 PF00069 6.9 Ki ChEMBL
Q9H2G2 SLK Homo sapiens Human PF00069 PF12474 6.9 Ki ChEMBL
O95819 MAP4K4 Homo sapiens Human PF00780 PF00069 6.8 Ki ChEMBL
P23443 RPS6KB1 Homo sapiens Human PF00069 PF00433 6.8 Ki ChEMBL
P49840 GSK3A Homo sapiens Human PF00069 6.8 Ki ChEMBL
Q04912 MST1R Homo sapiens Human PF07714 PF01437 PF01403 PF01833 6.8 Ki ChEMBL
Q9Y4K4 MAP4K5 Homo sapiens Human PF00780 PF00069 6.8 Ki ChEMBL
Q16513 PKN2 Homo sapiens Human PF02185 PF00069 PF00433 6.6 Ki ChEMBL
P16591 FER Homo sapiens Human PF00611 PF07714 PF00017 6.5 Ki ChEMBL
P35916 FLT4 Homo sapiens Human PF07679 PF13927 PF22971 PF07714 PF21339 PF17988 PF22854 6.5 Ki ChEMBL
Q86V86 PIM3 Homo sapiens Human PF00069 6.5 Ki ChEMBL
P35968 KDR Homo sapiens Human PF07679 PF00047 PF13895 PF22971 PF07714 PF21339 PF17988 PF22854 6.4 Ki ChEMBL
P41743 PRKCI Homo sapiens Human PF00130 PF00564 PF00069 PF00433 6.4 Ki ChEMBL
P31749 AKT1 Homo sapiens Human PF00169 PF00069 PF00433 6.3 Ki ChEMBL
P34947 GRK5 Homo sapiens Human PF00069 PF00615 6.2 Ki ChEMBL
P52333 JAK3 Homo sapiens Human PF18379 PF18377 PF17887 PF07714 PF21990 6.2 Ki ChEMBL
Q13131 PRKAA1 Homo sapiens Human PF16579 PF21147 PF00069 6.2 Ki ChEMBL
Q9HBY8 SGK2 Homo sapiens Human PF00069 PF00433 6.2 Ki ChEMBL
P49841 GSK3B Homo sapiens Human PF00069 6.2 IC50 ChEMBL
P04626 ERBB2 Homo sapiens Human PF00757 PF14843 PF07714 PF01030 PF21314 6.1 Ki ChEMBL
Q13976 PRKG1 Homo sapiens Human PF00027 PF16808 PF00069 6.1 Ki ChEMBL
P27448 MARK3 Homo sapiens Human PF02149 PF00069 PF00627 6.0 Ki ChEMBL
DrugBank Target Actions (3)
Target Gene Target Name Action Type
P05771 PRKCB Protein kinase C beta type inhibitor targets
P17252 PRKCA Protein kinase C alpha type inhibitor targets
Q04759 PRKCQ Protein kinase C theta type inhibitor targets